New Zippered Lab Coat from Kimberly-Clark Professional Offers Reduced Risk of Contamination
In response to customer requests for a more secure closure, the company equipped the new lab coat with a nylon zipper and no-pocket design, rather than the typical snap design, which runs the risk of contamination to people and processes.
On Oct. 25, 2019, Kimberly-Clark Professional, a personal care corporation headquartered in Irving, TX, introduced the Kimtech A8 Zippered Lab Coat for liquid and particle protection for ISO 7 and 8 or higher cleanroom environments.
In response to customer requests for a more secure closure, the company equipped the new lab coat with a nylon zipper and no-pocket design, rather than the typical snap design, which runs the risk of contamination to people and processes because of gaps between the closures and the possibility of the snaps falling off, according to a company press release.
The lab coat is available in sizes small to 6XL with anti-static three-layer spunbond meltblown spunbond fabric, a mandarin collar for added protection, and soft knit cuffs. It can also be recycled through The RightCycle Program, a recycling program for non-hazardous lab, cleanroom, and industrial waste.
Source: Kimberly-Clark Professional
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
